{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:53:35Z","timestamp":1790488415137,"version":"4.1.0"},"reference-count":70,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Lo Kwee Seong Biomedical Research Fund"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971706"],"award-info":[{"award-number":["81971706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>COVID-19 has become a major public health problem. There is good evidence that ACE2 is a receptor for SARS-CoV-2, and high expression of ACE2 may increase susceptibility to infection. We aimed to explore risk factors affecting susceptibility to infection and prioritize drug repositioning candidates, based on Mendelian randomization (MR) studies on ACE2 lung expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>We conducted a phenome-wide MR study to prioritize diseases\/traits and blood proteins causally linked to ACE2 lung expression in GTEx. We also explored drug candidates whose targets overlapped with the top-ranked proteins in MR, as these drugs may alter ACE2 expression and may be clinically relevant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The most consistent finding was tentative evidence of an association between diabetes-related traits and increased ACE2 expression. Based on one of the largest genome-wide association studies on type 2 diabetes mellitus (T2DM) to date (N = 898,130), T2DM was causally linked to raised ACE2 expression (P = 2.91E\u221203; MR-IVW). Significant associations (at nominal level; P &amp;lt; 0.05) with ACE2 expression were observed across multiple diabetes data sets and analytic methods for T1DM, T2DM, and related traits including early start of insulin. Other diseases\/traits having nominal significant associations with increased expression included inflammatory bowel disease, (estrogen receptor\u2013positive) breast cancer, lung cancer, asthma, smoking, and elevated alanine aminotransferase. We also identified drugs that may target the top-ranked proteins in MR, such as fostamatinib and zinc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Our analysis suggested that diabetes and related traits may increase ACE2 expression, which may influence susceptibility to infection (or more severe infection). However, none of these findings withstood rigorous multiple testing corrections (at false discovery rate &amp;lt;0.05). Proteome-wide MR analyses might help uncover mechanisms underlying ACE2 expression and guide drug repositioning. Further studies are required to verify our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc20-0643","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T20:11:01Z","timestamp":1589919061000},"page":"1416-1426","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":193,"title":["Exploring Diseases\/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits"],"prefix":"10.2337","volume":"43","clinical-trial-number":[{"clinical-trial-number":"nct04342728","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04326725","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04351490","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-4684","authenticated-orcid":false,"given":"Shitao","family":"Rao","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Lau","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-833X","authenticated-orcid":false,"given":"Hon-Cheong","family":"So","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong"},{"name":"Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China"},{"name":"KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Kunming Institute of Zoology and The Chinese University of Hong Kong, Shatin, Hong Kong"},{"name":"Department of Psychiatry, The Chinese University of Hong Kong, Shatin, Hong Kong"},{"name":"Margaret K.L. Cheung Research Centre for Management of Parkinsonism, The Chinese University of Hong Kong, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"2022031300294862300_B1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"2022031300294862300_B2","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume-title":"Zhonghua liu xing bing xue za zhi","author":"Novel Coronavirus Pneumonia Emergency Response Epidemiology Team","year":"2020"},{"key":"2022031300294862300_B3","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2022031300294862300_B4","unstructured":"World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report \u2013 93 [Internet], 2020. Available from https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200422-sitrep-93-covid-19.pdf?sfvrsn=35cf80d7_4. Accessed 22 April 2020"},{"key":"2022031300294862300_B5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"2022031300294862300_B6","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"2022031300294862300_B7","author":"Zhou"},{"key":"2022031300294862300_B8","author":"Wrapp"},{"key":"2022031300294862300_B9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"2022031300294862300_B10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"2022031300294862300_B11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor","volume":"319","author":"Hofmann","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031300294862300_B12","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol"},{"key":"2022031300294862300_B13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"2022031300294862300_B14","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1055-9965.EPI-19-0036","article-title":"A phenome-wide Mendelian randomization study of pancreatic cancer using summary genetic data","volume":"28","author":"Langdon","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022031300294862300_B15","doi-asserted-by":"crossref","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","article-title":"Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide Mendelian randomization study","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med"},{"key":"2022031300294862300_B16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ije\/dyz182","article-title":"Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study","volume":"48","author":"Meng","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2022031300294862300_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"2022031300294862300_B18","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2022031300294862300_B19","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1371\/journal.pmed.0040352","article-title":"Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology","volume":"4","author":"Smith","year":"2007","journal-title":"PLoS Med"},{"key":"2022031300294862300_B20","author":"Schmidt"},{"key":"2022031300294862300_B21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"2022031300294862300_B22","doi-asserted-by":"crossref","first-page":"e1006706","DOI":"10.1371\/journal.pgen.1006706","article-title":"Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease","volume":"13","author":"Folkersen","year":"2017","journal-title":"PLoS Genet"},{"key":"2022031300294862300_B23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0962280216660127","article-title":"A two-stage model in a Bayesian framework to estimate a survival endpoint in the presence of confounding by indication","volume":"27","author":"Bellera","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2022031300294862300_B24","unstructured":"UK_Biobank_GWAS \/ imputed-v2-gwas \/ [Internet]. Available from https:\/\/github.com\/Nealelab\/UK_Biobank_GWAS\/tree\/master\/imputed-v2-gwas. Accessed 3 March 2020"},{"key":"2022031300294862300_B25","unstructured":"Details and considerations of the UK Biobank GWAS [Internet], 2017. Available from http:\/\/www.nealelab.is\/blog\/2017\/9\/11\/details-and-considerations-of-the-uk-biobank-gwas. Accessed 3 March 2020"},{"key":"2022031300294862300_B26","unstructured":"MRC IEU UK Biobank GWAS pipeline version 2 [Internet], 2019. Available from 10.5523\/bris.pnoat8cxo0u52p6ynfaekeigi. Accessed 3 March 2020"},{"key":"2022031300294862300_B27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1534\/genetics.117.300360","article-title":"Transformation of summary statistics from linear mixed model association on all-or-none traits to odds ratio","volume":"208","author":"Lloyd-Jones","year":"2018","journal-title":"Genetics"},{"key":"2022031300294862300_B28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41588-018-0154-4","article-title":"Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation","volume":"50","author":"Gamazon","year":"2018","journal-title":"Nat Genet"},{"key":"2022031300294862300_B29","unstructured":"Analysis methods [Internet], 2019. Available from https:\/\/gtexportal.org\/home\/documentationPage#staticTextAnalysisMethods. Accessed 3 March 2020"},{"key":"2022031300294862300_B30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2022031300294862300_B31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2022031300294862300_B32","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2022031300294862300_B33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"2022031300294862300_B34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"key":"2022031300294862300_B35","doi-asserted-by":"crossref","unstructured":"Zhao\u2008Q, Wang\u2008J, Hemani\u2008G, Bowden\u2008J, Small\u2008DS. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. 29 January 2018 [preprint]. arXiv:1801.09652","DOI":"10.32614\/CRAN.package.mr.raps"},{"key":"2022031300294862300_B36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"2022031300294862300_B37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [published correction appears in Nat Genet 2018;50:1196]","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"2022031300294862300_B38","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10654-018-0424-6","article-title":"Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates","volume":"33","author":"Burgess","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"2022031300294862300_B39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"2022031300294862300_B40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"2022031300294862300_B41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/01621459.2014.990973","article-title":"False discovery rate regression: an application to neural synchrony detection in primary visual cortex","volume":"110","author":"Scott","year":"2015","journal-title":"J Am Stat Assoc"},{"key":"2022031300294862300_B42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.2897","article-title":"Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility","volume":"46","author":"Mahajan","year":"2014","journal-title":"Nat Genet"},{"key":"2022031300294862300_B43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031300294862300_B44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2022031300294862300_B45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"2022031300294862300_B46","article-title":"Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis","author":"Guan","journal-title":"Eur Respir J"},{"key":"2022031300294862300_B47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12250-015-3679-z","article-title":"Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia","volume":"31","author":"Banik","year":"2016","journal-title":"Virol Sin"},{"key":"2022031300294862300_B48","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268818002923","article-title":"Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study","volume":"147","author":"Alqahtani","year":"2019","journal-title":"Epidemiol Infect"},{"key":"2022031300294862300_B49","doi-asserted-by":"crossref","first-page":"e131774","DOI":"10.1172\/jci.insight.131774","article-title":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection","volume":"4","author":"Kulcsar","year":"2019","journal-title":"JCI Insight"},{"key":"2022031300294862300_B50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2022031300294862300_B51","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","author":"Monteil","journal-title":"Cell"},{"key":"2022031300294862300_B52","unstructured":"Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 [Internet], 2020. Available from https:\/\/ClinicalTrials.gov\/show\/NCT04335136. Accessed 9 May 2020"},{"key":"2022031300294862300_B53","article-title":"SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drugrepurposing","volume-title":"bioRxiv","author":"Gordon","year":"2020"},{"key":"2022031300294862300_B54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"2022031300294862300_B55","article-title":"Antihypertensive treatment with ACEI\/ARB of patients with COVID-19 complicated by hypertension","author":"Li","journal-title":"Hypertens Res"},{"key":"2022031300294862300_B56","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2022031300294862300_B57","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"2022031300294862300_B58","doi-asserted-by":"crossref","first-page":"F1297","DOI":"10.1152\/ajprenal.00110.2010","article-title":"The ANG-(1-7)\/ACE2\/mas axis in the regulation of nephron function","volume":"298","author":"Ferrario","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031300294862300_B59","doi-asserted-by":"crossref","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats","volume":"289","author":"Igase","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022031300294862300_B60","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"2022031300294862300_B61","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"2022031300294862300_B62","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2022031300294862300_B63","doi-asserted-by":"crossref","first-page":"e00175","DOI":"10.1002\/prp2.175","article-title":"In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib","volume":"3","author":"Rolf","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"2022031300294862300_B64","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2019.00897","article-title":"Efficacy and safety of multiple dosages of fostamatinib in adult patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Kang","year":"2019","journal-title":"Front Pharmacol"},{"key":"2022031300294862300_B65","first-page":"1532","article-title":"Therapeutic targeting of Syk in autoimmune diabetes [published correction appears in J Immunol 2011;187:1516]","volume-title":"J Immunol","author":"Colonna","year":"2010"},{"key":"2022031300294862300_B66","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ije\/dyp391","article-title":"Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials","volume":"39","author":"Roth","year":"2010","journal-title":"Int J Epidemiol"},{"key":"2022031300294862300_B67","first-page":"Suppl. 1","article-title":"Concentration-dependent effects of zinc on angiotensin-converting enzyme-2 activity (1067.4) (Abstract)","volume-title":"FASEB J","author":"Speth","year":"2014"},{"key":"2022031300294862300_B68","doi-asserted-by":"crossref","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"te Velthuis","year":"2010","journal-title":"PLoS Pathog"},{"key":"2022031300294862300_B69","article-title":"Zinc and respiratory tract infections: perspectives for COVID-19 (Review)","author":"Skalny","journal-title":"Int J Mol Med"},{"key":"2022031300294862300_B70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gepi.20589","article-title":"The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery","volume":"35","author":"Pendergrass","year":"2011","journal-title":"Genet Epidemiol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc20-0643","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/7\/1416\/630705\/dc200643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/7\/1416\/630705\/dc200643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:24:57Z","timestamp":1722893097000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/7\/1416\/35591\/Exploring-Diseases-Traits-and-Blood-Proteins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":70,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,5,19]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-0643","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.04.20031237","asserted-by":"object"}]},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]}}}